Top
Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
Yeungnam University Journal of Medicine
Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab
DOI: 10.12701/yujm.2020.00878, Volume: 38, Issue: 3, Pages: 251-257
Article Type: case-report,
Article History
received:
rev-recd:
accepted:
published:
-
-
-
- Altmetric
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.12701/yujm.2020.00878&title=Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab&author=&keyword=[{keywordId=1022, uniqueName=child, name=Child, contentId=238025}, {keywordId=1866, uniqueName=tuberculosis, name=Tuberculosis, contentId=238025}, {keywordId=6074, uniqueName=infliximab, name=Infliximab, contentId=238025}, {keywordId=20676, uniqueName=inflammatory-bowel-diseases, name=Inflammatory bowel diseases, contentId=238025}, {keywordId=62935, uniqueName=vedolizumab, last=true, name=Vedolizumab, contentId=238025}],[{keywordId=1022, uniqueName=child, name=Child, contentId=238025}, {keywordId=1866, uniqueName=tuberculosis, name=Tuberculosis, contentId=238025}, {keywordId=6074, uniqueName=infliximab, name=Infliximab, contentId=238025}, {keywordId=20676, uniqueName=inflammatory-bowel-diseases, name=Inflammatory bowel diseases, contentId=238025}, {keywordId=62935, uniqueName=vedolizumab, last=true, name=Vedolizumab, contentId=238025}],[{keywordId=1022, uniqueName=child, name=Child, contentId=238025}, {keywordId=1866, uniqueName=tuberculosis, name=Tuberculosis, contentId=238025}, {keywordId=6074, uniqueName=infliximab, name=Infliximab, contentId=238025}, {keywordId=20676, uniqueName=inflammatory-bowel-diseases, name=Inflammatory bowel diseases, contentId=238025}, {keywordId=62935, uniqueName=vedolizumab, last=true, name=Vedolizumab, contentId=238025}],[{keywordId=1022, uniqueName=child, name=Child, contentId=238025}, {keywordId=1866, uniqueName=tuberculosis, name=Tuberculosis, contentId=238025}, {keywordId=6074, uniqueName=infliximab, name=Infliximab, contentId=238025}, {keywordId=20676, uniqueName=inflammatory-bowel-diseases, name=Inflammatory bowel diseases, contentId=238025}, {keywordId=62935, uniqueName=vedolizumab, last=true, name=Vedolizumab, contentId=238025}],[{keywordId=1022, uniqueName=child, name=Child, contentId=238025}, {keywordId=1866, uniqueName=tuberculosis, name=Tuberculosis, contentId=238025}, {keywordId=6074, uniqueName=infliximab, name=Infliximab, contentId=238025}, {keywordId=20676, uniqueName=inflammatory-bowel-diseases, name=Inflammatory bowel diseases, contentId=238025}, {keywordId=62935, uniqueName=vedolizumab, last=true, name=Vedolizumab, contentId=238025}],&subject=
© 2024 Newgen KnowledgeWorks |
Privacy & Cookie Policy | Powered by: Nova